Bicycle Therapeutics plc - ADR (BCYC)
NASDAQ
3.57
-0.03 (-0.83%)
Closed
Oct 21, 2026
Day's Range
3.563.80
52 wk Range
3.339.08
Financial Statements - BCYC - Bicycle Therapeutics plc - ADR
Revenue
72.58M▲ 105.8%
Net Income
-218.96M▼ 29.5%Net Margin -301.7%
EBITDA
-212.83M▼ 30.4%
Free Cash Flow
-252.02M▼ 51.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 72.58M | 35.27M | 26.97M | 14.46M | 11.69M | 10.39M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -247.71M | -209.15M | -189.35M | -116.09M | -65.61M | -51.96M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 653K | 2.80M | -594K | -555K | 358K | - |
| Pre Tax Income | -218.80M | -173.79M | -179.20M | -114.24M | -68.48M | -51.73M |
| Income Tax | 152K | -4.76M | 1.45M | -1.52M | -1.66M | -724K |
| Net Income | -218.96M | -169.03M | -180.66M | -112.71M | -66.81M | -51.01M |
| EPS Basic | -3.16 | -2.9 | -5.08 | -3.8 | -2.67 | -2.66 |
| EPS Diluted | -3.16 | -2.9 | -5.08 | -3.8 | -2.67 | -2.66 |
| Basic Shares Outstanding | 69.27M | 58.20M | 35.59M | 29.66M | 25.06M | 19.14M |
| Diluted Shares Outstanding | 69.27M | 58.20M | 35.59M | 29.66M | 25.06M | 19.14M |
| Ebit | -218.60M | -172.06M | -175.94M | -110.89M | -65.49M | -51.27M |
| Ebitda | -212.83M | -163.21M | -168.80M | -106.65M | -64.08M | -50M |
| Net Income Continuous Operations | -218.96M | -169.03M | -180.66M | -112.71M | -66.81M | -51.01M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
